Literature DB >> 2297207

A case of the eosinophilia-myalgia syndrome associated with use of an L-tryptophan product.

M T Flannery1, P M Wallach, L R Espinoza, M P Dohrenwend, L C Moscinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2297207     DOI： 10.7326/0003-4819-112-4-300

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.

Authors:  W F Owen; J Petersen; D M Sheff; R D Folkerth; R J Anderson; J M Corson; A L Sheffer; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 2.  Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis.

Authors:  P J Maddison
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Two patients with eosinophilia myalgia syndrome associated with tryptophan.

Authors:  L G van Garsse; P P Boeykens
Journal:  BMJ       Date:  1990-07-07

4.  Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.

Authors:  A M Cilursu; J Goeken; R R Olson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.